The latest price target for Genenta Science (NASDAQ:GNTA) was reported by HC Wainwright & Co. on October 2, 2024. The analyst firm set a price target for $25.00 expecting GNTA to rise to within 12 months (a possible 380.77% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Genenta Science (NASDAQ:GNTA) was provided by HC Wainwright & Co., and Genenta Science reiterated their buy rating.

There is no last upgrade for Genenta Science

There is no last downgrade for Genenta Science.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genenta Science, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genenta Science was filed on October 2, 2024 so you should expect the next rating to be made available sometime around October 2, 2025.

While ratings are subjective and will change, the latest Genenta Science (GNTA) rating was a reiterated with a price target of $25.00 to $25.00. The current price Genenta Science (GNTA) is trading at is $5.20, which is out of the analyst’s predicted range.